FDA Inspection
Hill Dermaceuticals, Inc.Hill Dermaceuticals, Inc. – FDA Inspection, Oct 6, 2014
Record Details
This FDA Inspection record concerns Hill Dermaceuticals, Inc., with an inspection on October 6, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hill Dermaceuticals, Inc.
- Inspection Date
- October 6, 2014
- Product Type
- Drugs
View Company Profile
ID · ef929c10-eda2-4780-a237-7609d02d587f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 899290
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
- 21 CFR 211.194(d)Laboratory equipment calibration records
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hill Dermaceuticals, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2025 | VAI | Florida District Office | Drug Quality Assurance |
| August 11, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hill Dermaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.